Akron Biotech, a leading global supplier for the cell therapy industry receives ISO 9001:2008 Certification
Akron Biotechnology, LLC’s Quality Management System was registered on November 30th, 2012 on the requirements of ISO 9001:2008 standards by BSI Group America Inc. This ISO Certification emphasizes Akron Biotech’s commitment to quality and meeting their customers’ needs and expectations. It covers all relevant functions of the Company: development, production, storage and distribution of Akron Biotech’s products, i.e. cryopreservation media, recombinant proteins, media supplements, scaffolds and cell culture systems.
“This is an important step in our commitment to quality standards that will continue to enhance our products and services. We are looking forward to building upon this base towards a stronger foundation of excellence and compliance as we develop innovative products within our pipeline.” said Claudia Zylberberg, PhD, Akron’s President and CEO.